Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 1:05 pm Sale | 13G | ALIMERA SCIENCES INC ALIM | LYTTON LAURENCE W | 2,185,364 4.2% | -799,439 (-26.78%) | View |
2024-02-13 4:43 pm Sale | 13G | ALIMERA SCIENCES INC ALIM | BOOTHBAY FUND MANAGEMENT LLC | 3,198,708 6.1% | -1,585,772 (-33.14%) | View |
2024-02-13 4:24 pm Sale | 13G | ALIMERA SCIENCES INC ALIM | Stonepine Capital Management LLC | 5,373,732 9.99% | -3,979 (-0.07%) | View |
2024-02-13 4:06 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | HBM Healthcare Investments (Cayman) Ltd. | 466,666 0.9% | 466,666 (New Position) | View |
2024-02-13 3:27 pm Sale | 13G | ALIMERA SCIENCES INC ALIM | Altium Capital Management LP | 2,660,000 5% | -324,803 (-10.88%) | View |
2023-12-08 4:11 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | MORGAN STANLEY MS | 916,246 1.8% | 250,000 (+37.52%) | View |
2023-08-23 06:01 am Purchase | 13G | ALIMERA SCIENCES INC ALIM | Altium Capital Management LP | 2,984,803 5.7% | 2,984,803 (New Position) | View |
2023-08-16 5:17 pm Unchanged | 13D | ALIMERA SCIENCES INC ALIM | Velan Capital Investment Management LP | 13,610,358 26% | 0 (Unchanged) | View |
2023-08-14 12:20 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | LYTTON LAURENCE W | 2,984,803 5.7% | 2,984,803 (New Position) | View |
2023-08-10 5:26 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | Stonepine Capital Management LLC | 5,377,711 9.99% | 5,377,711 (New Position) | View |
2023-08-10 4:57 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | BOOTHBAY FUND MANAGEMENT LLC | 4,784,480 8.99% | 4,784,480 (New Position) | View |
2023-08-03 4:30 pm Sale | 13D | ALIMERA SCIENCES INC ALIM | Caligan Partners LP | 17,635,154 33.1% | -915,040,279,903 (-100.00%) | View |
2023-08-03 4:00 pm Purchase | 13D | ALIMERA SCIENCES INC ALIM | Velan Capital Investment Management LP | 13,610,358 26% | 11,948,879 (+719.17%) | View |
2023-05-19 4:00 pm Purchase | 13D | ALIMERA SCIENCES INC ALIM | Velan Capital Investment Management LP | 1,661,479 18.9% | 911,729 (+121.60%) | View |
2023-05-18 5:24 pm Purchase | 13D | ALIMERA SCIENCES INC ALIM | Caligan Partners LP | 915,057,915,057 9.99% | 915,057,190,341 (+126264245.63%) | View |
2023-04-03 2:24 pm Sale | 13G | ALIMERA SCIENCES INC ALIM | Palo Alto Investors LP | 0 0% | -802,423 (Position Closed) | View |
2023-03-31 11:00 am Purchase | 13D | ALIMERA SCIENCES INC ALIM | Velan Capital Investment Management LP | 749,750 9.99% | 749,750 (New Position) | View |
2023-03-28 5:00 pm Purchase | 13D | ALIMERA SCIENCES INC ALIM | Caligan Partners LP | 724,716 9.99% | 313,189 (+76.10%) | View |
2023-02-14 4:12 pm Unchanged | 13G | ALIMERA SCIENCES INC ALIM | Palo Alto Investors LP | 802,423 11.45% | 0 (Unchanged) | View |
2023-02-08 2:41 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | MORGAN STANLEY MS | 666,246 9.5% | 102,922 (+18.27%) | View |